check quantity

Bioware® Brite Cell Line LNCaP Red-FLuc

Our bioluminescent light-producing oncology cell lines are labeled with luciferase or dual labeled with luciferase and fluorescent reporters (GFP) for in vivo studies.

Please enter valid quantity

Please login to add favorites


Product Number

You successfully added item(s) to your cart


The LNCaP-Red-FLuc Bioware® Brite Cell Line is a light-producing cell line derived from LNCaP human prostate carcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red-FLuc), for a brighter, red-shifted signal.

  • Organism: Human
  • Tissue: Prostate; supraclavicular lymph node
  • Disease: Carcinoma
  • Optical Reporter: Red-Fluc

By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo.

After the cells are injected into an appropriate mouse model, the optimized Red-FLuc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.

Disclaimer: For laboratory use only. This product is intended for animal research only and not for use in humans.

Oncology Cell Line Prostate
Luciferase Classification Firefly
Product Brand Name Bioware Brite
Shipping Condition Dry Ice
Unit Size 2 million cells